These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30320570)

  • 21. Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease.
    Vijayan DK; Zhang KYJ
    Pharmacol Res; 2019 Sep; 147():104342. PubMed ID: 31288079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metalloprotease meprin β generates amino terminal-truncated amyloid β peptide species.
    Bien J; Jefferson T; Causević M; Jumpertz T; Munter L; Multhaup G; Weggen S; Becker-Pauly C; Pietrzik CU
    J Biol Chem; 2012 Sep; 287(40):33304-13. PubMed ID: 22879596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding.
    Scharfenberg F; Armbrust F; Marengo L; Pietrzik C; Becker-Pauly C
    Cell Mol Life Sci; 2019 Aug; 76(16):3193-3206. PubMed ID: 31201463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A pathogenic mechanism of N-terminally pyroglutamylated Aβ and possible application of Alzheimer's disease by inhibition of the pyroglutamylation].
    Iwata N; Asai M
    Rinsho Shinkeigaku; 2012; 52(11):1162-4. PubMed ID: 23196550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease.
    Portelius E; Olsson M; Brinkmalm G; Rüetschi U; Mattsson N; Andreasson U; Gobom J; Brinkmalm A; Hölttä M; Blennow K; Zetterberg H
    J Alzheimers Dis; 2013; 33(1):85-93. PubMed ID: 22886024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients.
    Bridel C; Hoffmann T; Meyer A; Durieux S; Koel-Simmelink MA; Orth M; Scheltens P; Lues I; Teunissen CE
    Alzheimers Res Ther; 2017 Jun; 9(1):38. PubMed ID: 28587659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of the Glutaminyl Cyclase Inhibitor PQ912 (Varoglutamstat) and the Murine Monoclonal Antibody PBD-C06 (m6) Shows Additive Effects on Brain Aβ Pathology in Transgenic Mice.
    Hoffmann T; Rahfeld JU; Schenk M; Ponath F; Makioka K; Hutter-Paier B; Lues I; Lemere CA; Schilling S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of glutaminyl cyclase inhibitors for Alzheimer's disease.
    Coimbra JR; Sobral PJ; Santos AE; Moreira PI; Salvador JA
    Future Med Chem; 2019 Dec; 11(24):3179-3194. PubMed ID: 31838899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium negatively regulates meprin β activity and attenuates substrate cleavage.
    Arnold P; Schmidt F; Prox J; Zunke F; Pietrzik C; Lucius R; Becker-Pauly C
    FASEB J; 2015 Aug; 29(8):3549-57. PubMed ID: 25957281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain.
    Hartlage-Rübsamen M; Staffa K; Waniek A; Wermann M; Hoffmann T; Cynis H; Schilling S; Demuth HU; Rossner S
    Int J Dev Neurosci; 2009 Dec; 27(8):825-35. PubMed ID: 19699792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design.
    Hoang VH; Tran PT; Cui M; Ngo VT; Ann J; Park J; Lee J; Choi K; Cho H; Kim H; Ha HJ; Hong HS; Choi S; Kim YH; Lee J
    J Med Chem; 2017 Mar; 60(6):2573-2590. PubMed ID: 28234463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides.
    Schlenzig D; Manhart S; Cinar Y; Kleinschmidt M; Hause G; Willbold D; Funke SA; Schilling S; Demuth HU
    Biochemistry; 2009 Jul; 48(29):7072-8. PubMed ID: 19518051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy.
    Hoffmann T; Meyer A; Heiser U; Kurat S; Böhme L; Kleinschmidt M; Bühring KU; Hutter-Paier B; Farcher M; Demuth HU; Lues I; Schilling S
    J Pharmacol Exp Ther; 2017 Jul; 362(1):119-130. PubMed ID: 28446518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
    Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
    Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the seeding and oligomerization of pGlu-amyloid peptides (in vitro).
    Schilling S; Lauber T; Schaupp M; Manhart S; Scheel E; Böhm G; Demuth HU
    Biochemistry; 2006 Oct; 45(41):12393-9. PubMed ID: 17029395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disturbed Ca2+ homeostasis increases glutaminyl cyclase expression; connecting two early pathogenic events in Alzheimer's disease in vitro.
    De Kimpe L; Bennis A; Zwart R; van Haastert ES; Hoozemans JJ; Scheper W
    PLoS One; 2012; 7(9):e44674. PubMed ID: 22970285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration.
    Becker A; Kohlmann S; Alexandru A; Jagla W; Canneva F; Bäuscher C; Cynis H; Sedlmeier R; Graubner S; Schilling S; Demuth HU; von Hörsten S
    BMC Neurosci; 2013 Oct; 14():108. PubMed ID: 24083638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's Aβ peptides with disease-associated N-terminal modifications: influence of isomerisation, truncation and mutation on Cu2+ coordination.
    Drew SC; Masters CL; Barnham KJ
    PLoS One; 2010 Dec; 5(12):e15875. PubMed ID: 21209855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Auraptene increases the production of amyloid-β via c-Jun N-terminal kinase-dependent activation of γ-secretase.
    Jung CG; Uhm KO; Horike H; Kim MJ; Misumi S; Ishida A; Ueda Y; Choi EK; Kim YS; Michikawa M; Hida H
    J Alzheimers Dis; 2015; 43(4):1215-28. PubMed ID: 25147119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.